CPT 84402: Free Testosterone Assay, Serum
Commercial payers pay $52 on average nationally for this procedure.
CPT code 84402 describes a laboratory assay measuring free testosterone concentration, typically performed on serum to assess endogenous androgen status; this service is a clinical chemistry endocrine test usually provided by a clinical laboratory in an outpatient or ambulatory setting or within hospital lab services.
For related coverage guidance, see recent payer policy updates: Salivary Hormone Testing, Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing, Bone Turnover Markers Testing.
Customize your policy alerts
Sign up for cpt 84402 policy alerts
Get alerted when payer policies referencing 84402 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial reimbursement for CPT 84402 centers around an average commercial (BUCA) rate of $51.80, with individual payers showing meaningful variation around that benchmark. Blue Cross Blue Shield presents the highest dispersion and highest endpoints among payers, while Aetna and Cigna sit nearer the BUCA mean on average; UnitedHealth Group’s central tendency is below BUCA. These differences indicate that network and contract structures produce distinct commercial positioning for this code across major carriers.
Examining dispersion (P75 minus P25) quantifies variability: Blue Cross Blue Shield’s interquartile spread is $29.10 (from $57.40 to $85.50), the widest among listed payers, signaling broader negotiated outcomes. UnitedHealth Group has the tightest spread at $14.30 (from $11.20 to $25.50), with Aetna ($12.00) and Cigna ($24.40) intermediate; BUCA interquartile spread is $23.00 (from $38.80 to $61.80).